# Rescue Progesterone Supplementation During Frozen Embryo Transfer

> **NCT05555121** · PHASE2 · SUSPENDED · sponsor: **Clinique Ovo** · enrollment: 150 (estimated)

## Conditions studied

- Fertility Issues
- Embryo Implantation
- Frozen Embryo Transfer

## Interventions

- **DRUG:** Progesterone Effervescent Vaginal Tablet

## Key facts

- **NCT ID:** NCT05555121
- **Lead sponsor:** Clinique Ovo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-12-01
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 150 (ESTIMATED)
- **Why stopped:** Study medication temporarly not available in Canada.
- **Last updated:** 2025-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05555121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05555121, "Rescue Progesterone Supplementation During Frozen Embryo Transfer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05555121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*